MTHFD2 and cancer: Interestingly, the MTHFD2 inhibitors are highly effective in killing a subset of cancer cells, but not all, indicating that neither the MTHFD2 RNAi nor CRISPR‐Cas9 KO cells predict the effects using the inhibitors.